For example, NCOA4 levels varied by ferroptosis inducer, with increased expression reported in hepatic stellate cells (HSCs) after sorafenib treatment, no differential expression in pancreatic cancer cells after elastin treatment, and elastin therapy resulted in even lower levels in MEFs or artesunate treatment in HSCs [62]. This evidence concerns the gene ELN and pancreatic neoplasm.